🔎 Trials Near Me

Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Texas

Pag-aaral pangklinika para sa Precursor T-Cell Lymphoblastic Leukemia-Lymphoma sa Texas

8 pag-aaral para sa Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

  • UT MD Anderson Cancer Center, Houston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07356245

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • M D Anderson Cancer Center, Houston
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT00501826

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

  • MD Anderson Cancer Center, Houston
  • Sarah Cannon Transplant and Cellular Therapy Methodist Hospital, San Antonio
Nagre-recruitPhase 2
6 Months · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06514794

A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)

  • MD Anderson Cancer Center, Houston
Nagre-recruitPhase 2
1 Month – 21 Years · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06561074

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

  • MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Hanggang edad 39 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04972942

Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma

  • UT MD Anderson, Houston
Nagre-recruitPhase 1
Edad 12 hanggang 30 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT07513129

A Registry for People With T-cell Lymphoma

  • MD Anderson Cancer Center (Data Collection Only), Houston
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update May 20, 2026 · NCT05978141

Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells

  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Nagre-recruitPhase 1
Hanggang edad 75 · Lahat ng kasarian · Na-update May 18, 2026 · NCT07220993

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.